Allison M. Gaudy
Allison M. Gaudy publishes mostly in Hematology, Molecular Biology and Oncology, on topics such as Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors and CAR-T cell therapy research.
- World rank
- #1,928,075 of 7,710,434 ranked researchers
- Rank in United States
- #587,968 of 1,627,098
- Works
- 48
- Citations
- 707
- Citations per work
- 14.7
What does Allison M. Gaudy research?
Allison M. Gaudy's work is mostly in Medicine (51%), Biochemistry, Genetics and Molecular Biology (18%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2551.2%
- Medicine2551.2%
- Everything else1530.4%
- Life Sciences918.4%
- 1Hematology22% of their works
- 2Molecular Biology18% of their works
- 3Oncology13% of their works
- 4Genetics7% of their works
- 5Pathology and Forensic Medicine5% of their works
- 6Radiology, Nuclear Medicine and Imaging4% of their works
Research topics
Which keywords describe Allison M. Gaudy's research?
The keywords of their largest research topics: Diagnosis Criteria, International Myeloma Working Group, BET Bromodomains, CAR T Cells, Chimeric Antigen Receptor, Prognostic Factors, PROTACs and Fc Receptors.
- Chronic Lymphocytic Leukemia
- Taxanes
- Chemotherapy-Induced Peripheral Neuropathy
- AML
- Fc Receptors
- PROTACs
- CAR T Cells
- International Myeloma Working Group
- Diagnosis Criteria
- BET Bromodomains
- Chimeric Antigen Receptor
- Prognostic Factors
- Therapeutic Antibodies
- Acute Myeloid Leukemia
- Pim Oncogenes
- Tumorigenesis
- Genomic Aberrations
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 17 words, with their numbers
- Diagnosis Criteria231 topic
- International Myeloma Working Group231 topic
- BET Bromodomains91 topic
- CAR T Cells91 topic
- Chimeric Antigen Receptor91 topic
- PROTACs91 topic
- Prognostic Factors92 topics
- Fc Receptors61 topic
- Therapeutic Antibodies61 topic
- AML51 topic
- Acute Myeloid Leukemia51 topic
- Chemotherapy-Induced Peripheral Neuropathy51 topic
- Pim Oncogenes51 topic
- Taxanes51 topic
- Tumorigenesis51 topic
- Chronic Lymphocytic Leukemia41 topic
- Genomic Aberrations41 topic
Where does Allison M. Gaudy work?
Allison M. Gaudy's main affiliation in the publication record is Bristol-Myers Squibb (United States), United States.
How many publications and citations does Allison M. Gaudy have?
OpenAlex counts 48 works and 707 citations for Allison M. Gaudy, an h-index of 13, ranking #1,928,075 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Allison M. Gaudy. Posts are plain text and can be reported.